Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision‐Making
European Journal of Haematology · 2026
DOI: 10.1111/ejh.70245 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Mamdouh Skafi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Emergency and Internal Medicine Department, Saint Joseph Hospital, East Jerusalem, Palestine. Hauptthemen laut MEDLINE: Lymphoma, B-Cell, Marginal Zone, Tumor Microenvironment, Clinical Decision-Making. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Extranodal marginal zone lymphoma (EMZL) represents a unique paradigm among indolent B‐cell neoplasms, in which lymphomagenesis is frequently driven by chronic antigenic stimulation within tissue‐specific microenvironments. Persistent infectious or autoimmune triggers promote the development of ectopic lymphoid tissue and sustain B‐cell activation, while recurrent genetic alterations—most prominently those that converge on NF‐κB signaling—enable progressive escape from antigen dependence. This dual biological foundation explains both the indolent clinical course of most cases and the remarkable therapeutic vulnerability of early‐stage, infection‐driven disease. Clinically, EMZL arise across a wide range of anatomical sites, each characterized by distinct etiologic associations and patterns of progression. As a result, management strategies must be tailored to disease site, stage, and biological context, with a consistent preference for the least intensive intervention capable of achieving durable disease control. Pathogen‐directed antibiotic therapy and involved‐site radiotherapy can be curative in localized disease. In contrast, systemic anti‐CD20‐based immunochemotherapy and targeted agents are reserved for disseminated, refractory, or biologically autonomous lymphomas. Recent advances in molecular profiling, functional imaging, and response assessment are refining risk stratification and treatment selection, shifting therapeutic goals toward early depth of response and quality of life rather than maximal cytotoxic intensity. EMZL thus serves as a model for biologically informed, precision‐oriented management of indolent lymphoid malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emergency and Internal Medicine Department, Saint Joseph Hospital, East Jerusalem, Palestine.
- Hematology Unit, Department of Onco-Hematology, AO of Cosenza, Cosenza, Italy.
- Department of Experimental and Clinical Medicine, University of Catanzaro, Catanzaro, Italy.
- Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy.
- Istituto di Fisiologia Clinica del CNR di Reggio Calabria, Consiglio Nazionale Delle Ricerche, Reggio Calabria, Italy.
- AIL Sezione di Cosenza, Cosenza, Italy.
ORCID-Profile: Marco Fiorillo, Francesco Mendicino, Massimo Gentile
Zitieren
APA
Skafi, M., Caserta, S., Martino, E. A., Vigna, E., Bruzzese, A., Amodio, N., Fiorillo, M., Lucia, E., D'Arrigo, G., Olivito, V., Labanca, C., Mendicino, F., Alvaro, M. E., Tripepi, G., Morabito, F., & Gentile, M. (2026). Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision‐Making. European Journal of Haematology. https://doi.org/10.1111/ejh.70245
Vancouver
Skafi M, Caserta S, Martino EA, Vigna E, Bruzzese A, Amodio N, et al. Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision‐Making. European Journal of Haematology. 2026. doi:10.1111/ejh.70245
BibTeX
@article{Skafi2026,
author = {Skafi, Mamdouh and Caserta, Santino and Martino, Enrica Antonia and Vigna, Ernesto and Bruzzese, Antonella and Amodio, Nicola and Fiorillo, Marco and Lucia, Eugenio and D'Arrigo, Graziella and Olivito, Virginia and Labanca, Caterina and Mendicino, Francesco and Alvaro, Maria Eugenia and Tripepi, Giovanni and Morabito, Fortunato and Gentile, Massimo},
title = {Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision‐Making},
journal = {European Journal of Haematology},
year = {2026},
doi = {10.1111/ejh.70245}
}
EUVIMED